StemCells, Inc. Announces First Human Neural Stem Cell Transplant in Landmark Myelination Disorder Trial
February 10, 2010 09:00 ET
|
StemCells, Inc.
PALO ALTO, Calif., Feb. 10, 2010 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM) announced today that its proprietary HuCNS-SC® human neural stem cells have been used to treat the first patient...
LifeTech Capital Initiates Research Coverage of StemCells, Inc. With Strong Speculative Buy Recommendation
February 03, 2010 09:00 ET
|
StemCells, Inc.
PALO ALTO, Calif., Feb. 3, 2010 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM) announced today that LifeTech Capital has initiated independent research coverage on the Company with a “Strong...
StemCells, Inc. Launches First Cell Culture Medium to Enable Derivation and Maintenance of True Rat Embryonic Stem Cells
January 25, 2010 09:00 ET
|
StemCells, Inc.
PALO ALTO, Calif., Jan. 25, 2010 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM) announced today the launch of GS1-R™, the first commercially available medium to enable the derivation,...